Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00243_DB00661_nanopub.RAASjmrssrPN-8XcsQycNmZs3B22f4oVqMqlgq7mq7iQo#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00243_DB00661 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00243_DB00661 label "DDI between Ranolazine and Verapamil - Verapamil, a CYP3A4 inhibitor, may increase the serum concentration of Ranolazine. Concomitant therapy is contraindicated. [drugbank_resource:DB00243_DB00661]" assertion.
- drugbank_resource:DB00243_DB00661 identifier "drugbank_resource:DB00243_DB00661" assertion.
- drugbank_resource:DB00243_DB00661 title "DDI between Ranolazine and Verapamil - Verapamil, a CYP3A4 inhibitor, may increase the serum concentration of Ranolazine. Concomitant therapy is contraindicated." assertion.
- drugbank:DB00661 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00243_DB00661 assertion.
- drugbank:DB00243 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00243_DB00661 assertion.